title: Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain.
abstract: Multilocus sequence typing and nrdA sequence analysis identified 6 different species or genogroups and 13 sequence types (STs) among 15 Achromobacter isolates from cystic fibrosis (CF) patients and 7 species or genogroups and 11 STs among 11 isolates from non-CF patients. Achromobacter xylosoxidans was the most frequently isolated species among CF patients.
authors.affiliation: Servicio de Microbiología Clínica, Hospital Universitario 12 de Octubre, Madrid, Spain.
authors.forename: Laura
authors.initials: L
authors.lastname: Barrado
authors.forename: Patricia
authors.initials: P
authors.lastname: Brañas
authors.forename: M Ángeles
authors.initials: MÁ
authors.lastname: Orellana
authors.forename: M Teresa
authors.initials: MT
authors.lastname: Martínez
authors.forename: Gloria
authors.initials: G
authors.lastname: García
authors.forename: Joaquín R
authors.initials: JR
authors.lastname: Otero
authors.forename: Fernando
authors.initials: F
authors.lastname: Chaves
mesh_terms: D042402:Achromobacter / Q000145:classification* / Q000235:genetics* / Q000302:isolation & purification; D000293:Adolescent; D000328:Adult; D001426:Bacterial Proteins / Q000235:genetics; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D005260:Female; D005838:Genotype; D016905:Gram-Negative Bacterial Infections / Q000382:microbiology*; D006801:Humans; D008297:Male; D058889:Molecular Typing; D017422:Sequence Analysis, DNA; D013030:Spain; D055815:Young Adult
chemical_list: D001426:Bacterial Proteins; D004269:DNA, Bacterial
references.citation: Syst Appl Microbiol. 2013 Feb;36(1):1-10
references.pmid: 23219252
references.citation: Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):336-9
references.pmid: 15024624
references.citation: Antimicrob Agents Chemother. 2005 Jan;49(1):104-10
references.pmid: 15616282
references.citation: Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):973-80
references.pmid: 21279730
references.citation: J Cyst Fibros. 2007 Jan;6(1):75-8
references.pmid: 16793350
references.citation: Antimicrob Agents Chemother. 2008 Jun;52(6):1952-6
references.pmid: 18362192
references.citation: Diagn Microbiol Infect Dis. 2011 Jul;70(3):408-11
references.pmid: 21497041
references.citation: Clin Infect Dis. 1997 Feb;24(2):274-5
references.pmid: 9114166
references.citation: Antimicrob Agents Chemother. 2013 Jan;57(1):603-5
references.pmid: 23089757
references.citation: J Clin Microbiol. 2011 Oct;49(10):3649-51
references.pmid: 21849686
references.citation: J Cyst Fibros. 2013 May;12(3):298-301
references.pmid: 23141756
references.citation: J Cyst Fibros. 2010 Jan;9(1):51-8
references.pmid: 19939747
references.citation: J Cyst Fibros. 2005 Mar;4(1):41-8
references.pmid: 15752680
references.citation: J Clin Microbiol. 2012 Sep;50(9):3010-5
references.pmid: 22785192
references.citation: J Clin Microbiol. 2012 Aug;50(8):2688-94
references.pmid: 22675125
references.citation: APMIS. 2008 Sep;116(9):837-41
references.pmid: 19024606
references.citation: Clin Infect Dis. 1998 Jul;27(1):158-63
references.pmid: 9675470
references.citation: Chest. 2009 Dec;136(6):1554-1560
references.pmid: 19505987
references.citation: J Clin Microbiol. 2001 Oct;39(10):3597-602
references.pmid: 11574579
references.citation: Clin Microbiol Rev. 2010 Apr;23(2):299-323
references.pmid: 20375354